Healthcare, Drug Delivery, Health Technology, Healthtech, Octopus Insights.
space is still quite limited, with a tilt towards the larger US market. Whilst the long regulatory timeline has likely restricted the amount of investment into startups focused on next gen drug delivery, there have recently been a number of positive signals. The US Food and Drug Administration